Emergent Biosolutions Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.90

-0.35 (-5.60%)

As of Nov 5, 2:28 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 5 71%

Hold 1 14%

Sell 1 14%

Price Target

Analyst Price Target +359.0% upside

Low Target $18.81

Average Target $27.08

High Target $37.55

Current Price $5.90

Current
$5.90

Target
$27.08

$18.81 $27.08 avg $37.55

Scenario Analysis

Bear Case

$18.81

218.8%

Low target

Base Case

$27.08

+359.0%

Avg target

Bull Case

$37.55

+536.4%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$14.06

-58.0% from high

52-Week Low

$4.36

+35.3% from low

Target vs 52W High

$27.08

+92.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%